Man Group plc - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
Man Group plc ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$26,423,000
+275.8%
310,752
+56.6%
0.10%
+197.1%
Q2 2020$7,032,000
+2420.4%
198,432
+860.6%
0.04%
+1650.0%
Q1 2020$279,000
-77.3%
20,658
-67.7%
0.00%
-60.0%
Q1 2019$1,229,000
-71.1%
63,974
-78.6%
0.01%
-73.7%
Q4 2018$4,256,000
+0.5%
298,249
+46.8%
0.02%
+26.7%
Q3 2018$4,233,000
+49.0%
203,230
+69.4%
0.02%
+25.0%
Q2 2018$2,841,000120,0000.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders